Andere Sprachen Senvest Capital Inc.

Aktien

923428

CA81731L1094

SEC

Markt geschlossen - Toronto S.E. Andere Börsenplätze 17:20:21 29.04.2024			% 5 Tage	% 1. Jan.
290 ^CAD	+1.75%		+1.75%	-6.45%

29.03.	Senvest Capital Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Senvest Capital Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Focus Turns to -2-	04.04.
Biolinq Incorporated announced that it has received $58 million in funding from a group of investors	04.04.
Senvest Capital Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Senvest Capital Brief: Reporting net income attributable to common shareholders of $83.6 million or $33.78 per share for year ended December 31, 2023	28.03.
Senvest Capital Inc annonce ses résultats pour l’année financière terminée le 31 décembre 2023	28.03.
Senvest Capital Reports Results for the Year Ended December 31, 2023	28.03.
Biolinq Incorporated announced that it expects to receive funding	13.12.
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2022.	03.11.
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2023.	03.11.
Senvest Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03.11.
Senvest Capital Brief: Reported net loss attributable to common shareholders of ($67.0) million or ($27.07) per share for Q3	03.11.
Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 30 septembre 2023	03.11.
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023	03.11.
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023	03.11.
Senvest Capital Inc.'s Equity Buyback announced on August 11, 2022, has expired with 13,000 shares, representing 0.52% for CAD 3.96 million.	15.08.23
Senvest Capital Obtains TSX Consent For Normal Course Issuer Bid	11.08.23
Senvest Capital Inc. announces an Equity Buyback for 100,000 shares, representing 4.04% of its issued share capital.	11.08.23
Senvest Capital Brief: Announcing Acceptance by TSX of Normal Course Issuer Bid	11.08.23
Senvest Capital Inc. annonce que la TSX a approuvé son offre publique de rachat dans le cours normal des activités	11.08.23
Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid	11.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Senvest Capital Inc.

Aktien

923428

CA81731L1094

SEC

Andere Sprachen

Filter